{
    "clinical_study": {
        "@rank": "126029", 
        "acronym": "POP", 
        "arm_group": {
            "arm_group_label": "Surgisis\u00ae Soft Tissue Graft", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this Study is to collect information about the performance of the Surgisis\u00ae\n      Soft Tissue Graft (\"Study Product\") for the repair of pelvic organ prolapse in women."
        }, 
        "brief_title": "Soft Tissue Graft for Repair of Pelvic Organ Prolapse", 
        "completion_date": {
            "#text": "August 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Pelvic Organ Prolapse", 
        "condition_browse": {
            "mesh_term": [
                "Prolapse", 
                "Pelvic Organ Prolapse"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients in need of transvaginal surgical repair of primary (i.e., de novo) pelvic\n             organ prolapse.\n\n          -  POPQ = stage 2 or 3 in the vaginal compartment with the leading edge of prolapse\n             (i.e., more severe prolapse)\n\n          -  At least one symptom associated with prolapse (e.g., any of the following including\n             but not limited to vaginal bulge, vaginal pain/discomfort, voiding dysfunction,\n             manual reduction (digitation) needed for defecation, fecal incontinence, dyspareunia)\n\n        Exclusion Criteria:\n\n          -  Age < 18 years\n\n          -  BMI > 40\n\n          -  Not medically fit for transvaginal surgery under general or spinal anesthesia\n\n          -  Active UTI at the time of the index procedure as determined by urine culture\n\n          -  Vaginal atrophy (Note: Patient may be included after vaginal atrophy has been\n             effectively treated.)\n\n          -  Prior placement of synthetic mesh or biologic graft for pelvic organ prolapse\n\n          -  A history of  cervical, ovarian, uterine, endometrial, vaginal, vulval, colon, rectal\n             or bladder cancer\n\n          -  Currently planned obliterative surgical repair for pelvic organ prolapse\n\n          -  Systemic infection at the time of surgery\n\n          -  Requires chronic immunosuppressive therapy, including steroids or cytotoxic agents\n\n          -  Pregnant, breastfeeding or planning pregnancy during the study period\n\n          -  Previous diagnosis of collagen disorder (i.e., Marfan's, Ehlers-Danlos)\n\n          -  Physical allergies or cultural objections to the receipt of porcine products\n\n          -  Life expectancy of less than 12 months\n\n          -  Ongoing participation in an investigational device or drug trial\n\n          -  Currently undergoing evaluation or treatment for chronic pelvic pain (e.g., pain as a\n             result of interstitial cystitis, endometriosis, vulvodynia, pelvic congestion\n             syndrome)\n\n          -  Active vaginal infection at the time of the index procedure\n\n          -  History of pelvic inflammatory disease"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "45", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01827774", 
            "org_study_id": "12-015"
        }, 
        "intervention": {
            "arm_group_label": "Surgisis\u00ae Soft Tissue Graft", 
            "description": "Surgisis\u00ae Soft Tissue Graft for pelvic organ prolapse repair", 
            "intervention_name": "Surgisis\u00ae Soft Tissue Graft", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Pelvic organ prolapse", 
            "Graft repair"
        ], 
        "lastchanged_date": "May 23, 2014", 
        "location": {
            "contact": {
                "email": "sunxiuli918@126.com", 
                "last_name": "Xiuli SUN", 
                "phone": "+86-18611661856"
            }, 
            "facility": {
                "address": {
                    "city": "Beijing", 
                    "country": "China", 
                    "zip": "100044"
                }, 
                "name": "Peking University People's Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Post-Market Study of Surgisis\u00ae Soft Tissue Graft for Repair of Pelvic Organ Prolapse", 
        "overall_contact": {
            "email": "Tony.Wang@CookMedical.com", 
            "last_name": "Tony Wang", 
            "phone": "+86-10-6563-3366", 
            "phone_ext": "2300"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Rate of recurrence of pelvic organ prolapse", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01827774"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Cook", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cook", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}